Patritumab deruxtecan
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.
Supplier | Selleck Chemicals |
---|---|
Product # | D4004 |
Sku # | D4004-1mg*5 |
Pricing | 1mg*5, $2890.00 |